Research Analysts Set Expectations for USPH FY2024 Earnings

U.S. Physical Therapy, Inc. (NYSE:USPH) – Equities research analysts at William Blair lowered their FY2024 earnings per share (EPS) estimates for shares of U.S. Physical Therapy in a research note issued to investors on Tuesday, November 5th. William Blair analyst J. Haase now anticipates that the company will post earnings of $2.67 per share for the year, down from their previous forecast of $2.74. The consensus estimate for U.S. Physical Therapy’s current full-year earnings is $2.58 per share. William Blair also issued estimates for U.S. Physical Therapy’s Q4 2024 earnings at $0.74 EPS, Q1 2025 earnings at $0.59 EPS, Q2 2025 earnings at $0.81 EPS, Q4 2025 earnings at $0.81 EPS and FY2025 earnings at $3.12 EPS.

Several other equities research analysts also recently commented on the company. Barrington Research reaffirmed an “outperform” rating and set a $108.00 target price on shares of U.S. Physical Therapy in a report on Thursday. Bank of America reissued a “neutral” rating and issued a $90.00 price objective (down from $114.00) on shares of U.S. Physical Therapy in a research note on Monday, October 7th. Finally, StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, August 21st.

U.S. Physical Therapy Trading Down 1.9 %

Shares of NYSE USPH opened at $95.30 on Thursday. U.S. Physical Therapy has a 12 month low of $76.18 and a 12 month high of $113.63. The company has a market cap of $1.44 billion, a price-to-earnings ratio of 89.91, a P/E/G ratio of 3.93 and a beta of 1.38. The company has a quick ratio of 1.88, a current ratio of 1.88 and a debt-to-equity ratio of 0.28. The business has a fifty day simple moving average of $83.43 and a 200-day simple moving average of $91.56.

U.S. Physical Therapy (NYSE:USPH) last announced its earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share for the quarter, missing the consensus estimate of $0.82 by ($0.09). U.S. Physical Therapy had a net margin of 4.06% and a return on equity of 8.18%. The business had revenue of $167.19 million for the quarter, compared to the consensus estimate of $163.34 million. During the same period in the previous year, the firm earned $0.76 EPS. The firm’s revenue was up 10.4% on a year-over-year basis.

U.S. Physical Therapy Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Friday, November 15th will be given a $0.44 dividend. This represents a $1.76 annualized dividend and a yield of 1.85%. The ex-dividend date is Friday, November 15th. U.S. Physical Therapy’s payout ratio is currently 166.04%.

Insiders Place Their Bets

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,724 shares of the company’s stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total value of $142,230.00. Following the transaction, the chief operating officer now directly owns 7,038 shares of the company’s stock, valued at $580,635. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, Director Kathleen A. Gilmartin acquired 2,000 shares of the stock in a transaction dated Tuesday, September 3rd. The shares were acquired at an average price of $86.09 per share, with a total value of $172,180.00. Following the acquisition, the director now owns 18,904 shares in the company, valued at approximately $1,627,445.36. The trade was a 0.00 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, COO Graham D. Reeve sold 1,724 shares of the stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total value of $142,230.00. Following the sale, the chief operating officer now owns 7,038 shares of the company’s stock, valued at approximately $580,635. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.70% of the company’s stock.

Institutional Trading of U.S. Physical Therapy

Several hedge funds have recently added to or reduced their stakes in the business. Canada Pension Plan Investment Board bought a new stake in shares of U.S. Physical Therapy in the 2nd quarter worth approximately $28,000. Innealta Capital LLC bought a new stake in shares of U.S. Physical Therapy in the 2nd quarter worth approximately $30,000. Quest Partners LLC lifted its position in shares of U.S. Physical Therapy by 2,808.3% in the 2nd quarter. Quest Partners LLC now owns 349 shares of the company’s stock worth $32,000 after acquiring an additional 337 shares during the period. Quarry LP lifted its position in shares of U.S. Physical Therapy by 1,291.9% in the 2nd quarter. Quarry LP now owns 515 shares of the company’s stock worth $48,000 after acquiring an additional 478 shares during the period. Finally, Ridgewood Investments LLC bought a new stake in shares of U.S. Physical Therapy in the 2nd quarter worth approximately $51,000.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.